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ABSTRACT
Bacopa monnieri was also known as “Brahmi.” Theses plant has been considered as medicinal plants in Ayurvedic
systems for centuries. This present study was carried out to evaluate the antibacterial and antifungal properties of
ethanolic, diethyl ether, ethyl acetate, and aqueous extracts of B. monnieri. Agar disc diffusion tests were carried
out to determine the antimicrobial effects of ethanolic, diethyl ether, ethyl acetate and aqueous extracts of B.
monnieri against Gram-positive (Staphylococcus aureus ATCC 25923), Gram-negative (Escherichia coli ATCC
25922) bacterial strains and antifungal strains (Aspergillus flavus, and Candida albicans). Among the various
extracts, diethyl ether extracts of B. monnieri has an antibacterial potency against Staphylococcus aureus (gram
positive), and ethyl acetate extract showed effects on E. coli (gram negative) at higher concentrations of 300 µg
mL-1. The ethanolic extract has potent antifungal activity against the fungus (Aspergillus flavus, and Candida
albicans) compared to diethyl ether and ethyl acetate-ether. Both extracts (diethyl ether and ethyl acetate) has a
minimum antifungal effect while these extracts showed more inhibitory effects on tested bacteria. Inhibitory effects
of the aqueous extract were not observed at all concentration (100 µg mL-1, 200 µg mL-1and 300 µg mL-1)
against the entire examined bacterial and fungal species. The finding of this study indicates the antibacterial and
antifungal activity exhibited by the ethanolic, diethyl ether, and ethyl acetate extract of B. monnieri can be
validated to the management of medicinal plant throughout the world.
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INTRODUCTION
Medicinal herbs have been considered safe,
effective, and play an essential role in modern
pharmacology (1). B. monnieri is a creeping,
succulent, herb known as an essential medicinal
plant throughout the world (2). B. monnieri is used
medicinally for the treatment of insanity, epilepsy,
and skin disease, etc. (3). This plant has reported
as a sedative, vasoconstrictor, antimicrobial,
antifungal, anti-inflammatory, antiepileptic, and
anthelmintic activities (3). B. monnieri, also known
as Brahmi in the Ayurvedic medicine for centuries
(4). Antimicrobial properties of several parts of the
plant were included in this study. The entire plant is
being used as a nervous tonic (5). Identification,
separation, quantification, and standardization of
B. monnieri compounds was carried out over the
years. Explore antimicrobial compound in the
plants is an important study (6). Pharmacological
effects of B. monnieri is due to its active compounds
of alkaloids, sterols, saponins, hersaponin,
stigmasterol, beta-sitosterol, and bacopasaponins
etc. (7).Bacterial and fungal infection are severe for
immunologically deficient patients; an urgent need
for natural products may be useful and control
multidrug resistance in microbial activities.
Therefore, the reason of the present study was to
assess and investigate the B. monnieri extracts
effects against the different tested microbial
(bacteria and fungus) strains. This activity supports
in the treatment of infections caused by various
microorganisms. Infections due to microbes pose a
health problem around the world and their
resistance mechanisms have contributed to worse
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clinical outcomes. It is noteworthy to mention that
plants extracts are a possible source of
antimicrobial agents, alternative to cheap, and
effective herbal drugs to treat many disorders and
diseases against common bacterial infections.
Materials and Methods
Plant material
B. monnieri (whole plant) were selected from wild
vegetations in Selangor, Malaysia for the study. The
plant material was confirmed and authenticated at
Perdana University, Malaysia.
Preparation of various extract
The 250 grams fresh aerial parts of the plant's
materials were cleaned by removing dead
stems/roots/leaves or any other unwanted materials
and air-dried for 20 days. A measured quantity of
20 grams of dried powder was soaked in 200 ml
ethanol, diethyl ether, ethyl acetate and aqueous in
a round bottom flask at room temperature for 24
hours. Each extract was passed through filter paper
no1 (Whatman, England) at the end of extraction.
At room temperature, the filtrate was kept dry until
extract dried completely (8). The weight of the dried
extract was 0.78 grams. The yield of the extract
obtained was 3.20% (w/w). All the extracts were
stored in containers (airtight) at 48ºC for additional
testing.
Determination of Antibacterial and Antifungal
activities
Culture Media
The antibacterial test was carried out by Nutrient
Agar (NA) and Muller Hinton broth (MHB).
Sabaroud’s Dextrose Agar (SDA) was used for
fungal culture and susceptibility
test.
Inoculum
The bacteria were inoculated into Muller Hinton
broth (MHB and incubated at 370C for 4 hours and
confirm suspension for approximately 105 CFU/ml.
Similarly, fungal strains were inoculated into
Sabouraud’s dextrose broth for 6 hours.
Microorganisms
The antibacterial activity of ethanolic, diethyl ether,
ethyl acetate, and aqueous extract was determined
by individually testing on Gram-positive and Gram-
negative bacterial strains. The Gram-positive
(Staphylococcus aureus ATCC 25923) and Gram-
negative (Escherichia coli ATCC 25922) strains
were used. All the strains were cultured and
maintained on nutrient agar at 4°C. Two types of
medically important fungi (Aspergillus flavus, and
Candida albicans) were selected which causes
infection in human. Potential antibacterial and
antifungal properties of B. monnieri extracts were
measured in terms of zone of inhibition.
Drug used
Antibacterial (Ciprofloxacin 5 gm/ml) and
antifungal (clotrimazole 5 gm/ml) were used as
positive standard for tested microorganisms.
Antibacterial activity assay
The antibacterial activity was determined by agar
disc diffusion (9-10). A volume of 250 μl of the
bacterial culture (105CFU) was plated on the
Nutrient Agar (NA) plate and left it to dry.
Ethanolic, diethyl ether, ethyl acetate, and aqueous
acetate extract on 6 mm filter paper discs were
loaded for the concentration (0.1mL, 0.2mL, and
0.3mL) and kept for completely dry. Ciprofloxacin
discs (5mg/ml) was used as reference standard
control. The plates were incubated overnight at
37°C. The zone of inhibition (mm) on the surface of
each test organism around the paper disc were
determined according to the Clinical and
Laboratory Standards Institute for their antibacterial
activity (11). The average diameters of zones were
calculated after each test for 3 times.
Antifungal sensitivity test
All the extracts of B. monnieri were then tested for
their fungal toxicity against Aspergillus flavus and
Candida albicans. These extracts were added in
SDA agar medium for the concentration of 0.1mL,
0.2mL, and 0.3mL. Extracts added SDA medium
was solidified in Petri plates. Hardened 10 mm SDA
agar block was cut and placed at the center of the
actively growing Aspergillus flavus and Candia
albicans petri plates for incubation at 30°C for 7-
14 days (8). The average diameters were
measured. Clotrimazol used as positive control
standards.
Statistical Analysis
All the experiments were repeated for 3 times and
obtained data were expressed as standard
deviation.
Results
Ethanol, diethyl ether and ethyl acetate extract of
Bacopa monnieri at various concentration showed
the different inhibitory effect against bacteria (gram
positive and gram negative) as well as fungus.
Among various (ethanol, diethyl ether, and ethyl
acetate) extract of B. monnieri, diethyl ether showed
the maximum (18.36±38mm) inhibitory effect
against Staphylococcus aureus at higher
concentration (300 µg). The potency of ethanol
15.16±22 mm and ethyl acetate 8.20±10 mm,
respectively against gram-positive bacteria
(Staphylococcus aureus). In gram-negative bacteria
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(E. coli), various extract (ethanol, diethyl ether, and
ethyl acetate) showed the maximum 9.42±17,
11.06±38, and 13.3±28 respectively at higher
concentration (300 µg).The antifungal capability of
various extracts of B. monnieri showed a moderate
effect over all types of fungus (Aspergillus flavus
and Candida albicans). Ethanolic extracts were
found to have maximum activity (10.83±25)
followed by diethyl ether extract (8.61±14) and
ethyl acetate extract (6.66±22). Ethyl acetate
extract exhibited lesser inhibitory potency when
compared with ethanolic and diethyl ether extract.
At the concentration of 300 µg, all the extracts were
more effective against bacteria and fungus
compared to less concentration (100 µg and 200
µg) (Table 1). The inhibitory effect was not shown
by the aqueous extract against both bacteria and
fungus studied.
Table 1: Inhibitory effect of various extracts of Bacopa monnieri (Linn.) against pathogenic organisms
Microorg
anisms
Ethanol (µg mL-1) Diethyl ether (µg mL-1) Ethyl acetate (µg mL-1) Aqueous (µgmL-1)
100 200 300 100 200 300 100 200 300
1
0
0
2
0
0
3
0
0
Staphyloc
occus
aureus
8.93±
.04
10.23
±14
15.16
±22
12.16
±22
14.33
±67
18.36
±38
6.92
±32
7.40±
58
8.20
±10
N
A
N
A
N
A
Escherich
coli
5.42±
28
8.60
±24
9.42
±17
9.61
±14
9.80
±07
11.06
±38
11.8
±67
12.06
±38
13.3
±28
N
A
N
A
N
A
Aspergillu
s flavus
10.03
±52
10.43
± 17
10.83
±25
7.41
±88
7.55±
26
8.61±
14
4.52
±26
5.78±
28
6.66
±22
N
A
N
A
N
A
Candida
albicans
9.60±
22
10.5
±14
11.33
±33
6.36
±36
7.36
±14
8.66
±31
4.56
±43
5.23±
57
6.63
±38
N
A
N
A
N
A
Values are mean of three readings; NA: No activity found at this concentration; Standards: Ciprofloxacin
5mg/ml; Clotrimazole 5mg/ml.
Antimicrobial activities of the various extracts of Bacopa monnieri (Linn.) were tested against 2 pathogenic
bacteria and 2 fungi with standard antimicrobial agents (Ciprofloxacin5mg/ml) and antifungal
(Clotrimazole 5mg/ml). At the concentration of 300 µg, various plant extracts of B. monnieri and
antimicrobial agents were tested against microorganisms for their susceptibility (Figure 1).
Fig.1: Susceptibility patterns of both various extract of B. monnieri and antimicrobial agents.
Discussion
Antimicrobial activities of various plant sources are
existing treatment around the world (12). Numbers
of studies have been reported on the antimicrobial
properties of herbs, extraction of essential oil,
extracts, and decoctions. Bacopa monnieri plant
properties are anti-infective agents against various
types of bacteria and fungus (13). Medicinally, this
is also used for inflamed tissues (14). Compounds
of B. monnieri such as flavonoids, tannins, and
phenolic acid has effects on antimicrobial treatment
(15). Neurological disorders can be treated with
Bacopa monnieri (16).Results of the present study
showed that the various extract of B. monnieri
possesses antibacterial properties against human
pathogenic organisms, which are in agreement
with several studies reported (17-18). Among the
different concentration of extracts, diethyl ether
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extract inhibits Staphylococcus aureus growth at
higher concentration (300µg). All the extracts of B.
monnieri possessed antibacterial properties except
aqueous extracts showed no inhibitory effects on
the tested bacterial species. Gram-positive bacteria
were highly affected in comparison to gram-
negative bacteria by all the extracts except ethyl
acetate. Gram-positive bacteria exhibit a higher
susceptibility compared to gram-negative bacteria
by various plant extracts. Diethyl ether and ethyl
acetate extracts showed higher antibacterial activity
against gram-positive (Staphylococcus aureus) and
gram-negative (E.coli) bacteria respectively, which
is in agreement with several previous findings (8,
19).On the other hand, ethanolic extracts of B.
monnieri showed an elevated effect against both
the fungal species which is similar to a study by
Sampathkumar et al (20). The aqueous extract
remained non-responsive or inhibited the growth of
all tested fungus. These could be due to the loss of
some active compounds during the extraction
processes or topographical/environmental effect
leads to variation in contents. Besides, the
antimicrobial activities of the various extracts of B.
monnieri were observed and compared with the
standard drugs (Ciprofloxacin and Clotrimazole) at
a concentration of 300 µg against all the
microorganisms investigated.Development of
resistance mechanisms is a  never-ending process
by the microbes against known antibiotics (21-22).
Thus new antimicrobial compounds require a huge
concern in the medical field. This present study
provides evidence that B. monnieri is a promising
plant which has antimicrobial properties. However,
active ingredients and mechanism of action should
be enlightened and requires a further test against
various types of bacteria and fungus.
Conclusion
The present study has revealed that the B. monnieri
plant extracts is a potential antimicrobial agent
having a broad-spectrum activity. Thus, plants
derived chemicals should be a priority towards
sustainable management and appropriate
utilization of biodiversity. Further studies on the
isolation of pure compounds could exhibit an
exciting result.
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